| NCT ID | NCT07290387 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Rochester |
| Condition | Alzheimer Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 64 participants |
| Start Date | 2026-04-17 |
| Primary Completion | 2027-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 64 participants in total. It began in 2026-04-17 with a primary completion date of 2027-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Latino caregivers of individuals with Alzheimer's disease and related dementias experience high levels of stress burden and depressive symptoms and are underrepresented in caregiver intervention research. Tele Savvy is an evidence based caregiver education program that focuses on developing caregiver mastery skills. This study aims to culturally adapt the Tele Savvy intervention for Latino caregivers and evaluate its preliminary efficacy in a Stage 1b single arm clinical trial. The intervention is delivered remotely and includes weekly group sessions and asynchronous instructional videos. Primary outcomes focus on caregiver mastery with secondary outcomes including stress burden depressive symptoms and self efficacy.
Eligibility Criteria
Inclusion Criteria: * Identify as Hispanic or Latino * Age 18 years or older * Spanish speaking and able to read and write in Spanish * Provide at least four hours per week of care to a community dwelling loved one with Alzheimer's disease or related dementias * Have access to an electronic device and internet * Willing to participate in study interviews and intervention sessions Exclusion Criteria: * Physical or sensory conditions preventing use of a computer tablet or smartphone * Planning to move the care recipient to an institutional setting within six months
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07290387 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Alzheimer Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07290387 currently recruiting?
Yes, NCT07290387 is actively recruiting participants. Contact the research team at Maria_Quinones@URMC.Rochester.edu for enrollment information.
Where is the NCT07290387 trial being conducted?
This trial is being conducted at Rochester, United States.
Who is sponsoring the NCT07290387 clinical trial?
NCT07290387 is sponsored by University of Rochester. The trial plans to enroll 64 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.